Search Results - "Fukano, Reiji"
-
1
Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial
Published in Cancer science (01-12-2020)“…Anaplastic lymphoma kinase (ALK) inhibition is expected to be a promising therapeutic strategy for ALK‐positive malignancies. We aimed to examine the efficacy…”
Get full text
Journal Article -
2
Necrotic Change of Tunica Media Plays a Key Role in the Development of Coronary Artery Lesions in Kawasaki Disease
Published in Circulation Journal (25-09-2024)“…Background: Alarmins resulting from cell death or oxidative stress are involved in the development of Kawasaki disease (KD) vasculitis. In a previous study, we…”
Get full text
Journal Article -
3
Sarcopenia and obesity in long-term survivors of childhood leukemia/lymphoma: a report from a single institution
Published in Japanese journal of clinical oncology (01-07-2021)“…Background The incidence and background factors of sarcopenia and obesity in long-term survivors of childhood leukemia/lymphoma were not clear in Japan…”
Get full text
Journal Article -
4
-
5
Modeling and targeting of erythroleukemia by hematopoietic genome editing
Published in Blood (25-03-2021)“…Acute erythroid leukemia (AEL) is characterized by a distinct morphology, mutational spectrum, lack of preclinical models, and poor prognosis. Here, using…”
Get full text
Journal Article -
6
Histological characteristics of matrix metalloproteinase‐9 and tissue inhibitor of metalloproteinases‐1 in asthmatic murine model during A(H1N1)pdm09 infection
Published in Pathology international (01-10-2022)“…Pandemic influenza virus A(H1N1)pdm09 infection occurred in healthy children and young adults, but asthmatic patients presented more rapid progression of…”
Get full text
Journal Article -
7
The Effect of Vitamin K2 Supplementation on PIVKA-II Levels in Patients with Severe Motor and Intellectual Disabilities Undergoing Long-Term Tube Feeding
Published in Nutrients (01-10-2023)“…Nutritional support is essential for patients with severe motor and intellectual disabilities (SMID) to ensure the smooth provision of medical care. These…”
Get full text
Journal Article -
8
Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease
Published in Inflammation (01-02-2023)“…— Kawasaki disease (KD) is an acute, self-limiting, febrile systemic vasculitis of unknown cause associated with the development of coronary artery lesions…”
Get full text
Journal Article -
9
Low NUDT15 expression levels due to biallelic NUDT15 variants and 6‐mercaptopurine intolerance
Published in British journal of haematology (01-10-2022)“…Summary 6‐Mercaptopurine (6‐MP) is widely used for the treatment of paediatric leukaemia and lymphoma. Recently, germline variants in the NUDT15 gene have been…”
Get full text
Journal Article -
10
A single-center analysis of chronic graft-versus-host disease-free, relapse-free survival after alternative donor stem cell transplantation in children with hematological malignancies
Published in International journal of hematology (01-05-2017)“…We assessed the clinical outcomes of allogeneic hematopoietic stem cell transplantation (SCT) from alternative donors for pediatric patients with hematological…”
Get full text
Journal Article -
11
Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children’s Cancer Group Multicentre Trial, JPLSG B-NHL-20)
Published in BMJ open (19-03-2024)“…IntroductionChildren and adolescents with mature B cell non-Hodgkin lymphoma (B-NHL) are treated with short-intensive chemotherapy. The burden of short-term…”
Get full text
Journal Article -
12
BRAF V600E -positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis
Published in Haematologica (Roma) (17-03-2022)Get full text
Journal Article -
13
A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial
Published in Acta medica Okayama (01-08-2018)“…Crizotinib is an inhibitor of multiple tyrosine kinases, including the anaplastic lymphoma kinase (ALK). Responses to crizotinib have also been reported in…”
Get full text
Journal Article -
14
The effect of graft‐versus‐host disease on outcomes after allogeneic stem cell transplantation for refractory lymphoblastic lymphoma in children and young adults
Published in Pediatric blood & cancer (01-04-2020)“…Background Patients with relapsed or refractory lymphoblastic lymphoma (LBL) have a poor prognosis. The efficacy of allogeneic blood stem cell transplantation…”
Get full text
Journal Article -
15
Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma
Published in International journal of hematology (01-12-2019)“…We report a retrospective analysis of 38 patients (age ≤ 30 years) who underwent allogeneic hematopoietic stem cell transplantation (allo-SCT) for relapsed or…”
Get full text
Journal Article -
16
Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan
Published in British journal of haematology (01-02-2015)“…Summary To evaluate haematopoietic stem cell transplantation (HSCT) in children and adolescents, we reviewed the records of 47 patients who were ≤18 years, had…”
Get full text
Journal Article -
17
Hematopoietic stem cell transplantation following unsuccessful salvage treatment for relapsed acute lymphoblastic leukemia in children
Published in Pediatric blood & cancer (01-04-2015)“…Background For children who experience a re‐induction failure or multiple recurrences following the first relapse of acute lymphoblastic leukemia (ALL), it is…”
Get full text
Journal Article -
18
A Multicenter, Open-label, Clinical Trial to Assess the Effectiveness and Safety of Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-intensity Conditioning in Relapsed/refractory Anaplastic Large-cell Lymphoma in Children
Published in Acta medica Okayama (01-02-2020)“…No standard treatment for relapsed or refractory anaplastic large-cell lymphoma (ALCL) has been established. This study is a multicenter, open-label trial to…”
Get full text
Journal Article -
19
Effective VCR/DEX pulse maintenance therapy in the KYCCSG ALL-02 protocol for pediatric acute lymphoblastic leukemia
Published in International journal of hematology (01-02-2016)“…In a previous study of childhood acute lymphoblastic leukemia (ALL) by the Kyushu–Yamaguchi Children’s Cancer Study Group, ALL-96, we achieved a 72.1 % 5-year…”
Get full text
Journal Article -
20
Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma: study protocol for a non-randomized non-controlled trial
Published in Nagoya journal of medical science (01-08-2017)“…Currently, a standard therapy has not been established for recurrent or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. While…”
Get full text
Journal Article